Study to Demonstrate Consistency of Three Lots of a Live-attenuated Chikungunya Virus Vaccine Candidate in Healthy Adults
Clinical trial NCT04786444 · COMPLETED
Trial details
- NCT number
- NCT04786444
- Sponsor
- Valneva Austria GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-22
- Primary completion
- 2021-07-22
- Enrollment
- 409
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.